Ergebnis der Suchanfrage nach Campus

Fördergesellschaft IZB mbH

2

Record financing rounds at the Munich biotech hub

WHU - Otto Beisheim School of Management

Fan Reach and Sponsorship Value in Professional Women’s Football in Germany Could Triple By 2031, New WHU Delphi Study Finds

Leipzig Tourismus und Marketing GmbH

4

Four Hours in Leipzig – Sights of the City Centre

Deutsche Post DHL Group

PM: DHL Supply Chain baut seine Kapazitäten mit weiterem Logistikzentrum am Multi-User Campus in Leipzig/ Halle aus / PR: DHL Supply Chain expands capacities with new logistics center at multi-user campus in Leipzig/ Halle

GEA Group Aktiengesellschaft

3

GEA invests EUR 18 million in technology center for alternative proteins in the USA

Lamilux Heinrich Strunz GmbH

Innovations in the LAMILUX World

eROCKIT Group

7

PRESS RELEASE: eROCKIT Impresses at ICNC23 with Cutting-Edge Technology and Plans for Expansion

Deutsche Post DHL Group

2

PM: LEJ CAMPUS am DHL Drehkreuz Leipzig feierlich eröffnet / PR: LEJ CAMPUS at DHL’s Leipzig hub officially opened

WHU - Otto Beisheim School of Management

How we will consume sports in the future

Fördergesellschaft IZB mbH

Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris

Lamilux Heinrich Strunz GmbH

9

roda object report university library Magdeburg

Fördergesellschaft IZB mbH

Innovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio

Fördergesellschaft IZB mbH

2

The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics

Fördergesellschaft IZB mbH

2

Mk2 Biotechnolgies new start-up at the Innovation and Start-up Center Biotechnology (IZB) in Martinsried, near Munich, Germany

Fördergesellschaft IZB mbH

2

COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant

Fördergesellschaft IZB mbH

7

Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021

Fördergesellschaft IZB mbH

2

Lindis Biotech develops immunotherapy against bladder cancer

Fördergesellschaft IZB mbH

Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins

Fördergesellschaft IZB mbH

4

ChromoTek and Absolute Antibody Collaborate on Recombinant Engineered Antibodies

Fördergesellschaft IZB mbH

2

A higher omega-3 level apparently protects from dying from COVID-19

Bundesverband Solarwirtschaft e.V.

Press invitation / Berlin Energy Transition Dialogue 2021 / 16 and 17 March

Dear member of the media, There are new global challenges ahead of us, in the short run caused by the pandemic and in the long run caused by climate change and growing energy demand. Although worldwide support for the target of reaching climate neutrality by 2050 has increased, this process needs to be ...

Fördergesellschaft IZB mbH

3

World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools

Fördergesellschaft IZB mbH

KOPIE VON: Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups

Enclosed we send you the news of the day about the IZB. We would be pleased if you would consider the message in your news coverage. If you have any question ...

Fördergesellschaft IZB mbH

5

Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups

Fördergesellschaft IZB mbH

2

Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools

WHU - Otto Beisheim School of Management

FT MiM Ranking: World-Class WHU Master in Management in Germany

Fördergesellschaft IZB mbH

KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Fördergesellschaft IZB mbH

Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Fördergesellschaft IZB mbH

The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB

Fördergesellschaft IZB mbH

High investor density at the Pitch Day hosted by IZB